Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Giacomo d’Andrea

47 indexed publications match this author name.

ORCID: 0000-0002-6808-3960
OpenAlex: https://openalex.org/A5084245539

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 19 Receptor Pharmacology 18 Pharmacology 15 Chronic Pain 12 Toxicity 12 Mechanism of Action 10 Clinical Trial 10 Consciousness 9 Anxiety 8 Animal Study 7 Review Article 7 Treatment-Resistant Depression 7

Journals

Journal of Hepatology 3 Digestive and Liver Disease 3 Proceedings of the National Academy of Sciences 3 Neuroscience Applied 2 Translational Psychiatry 1 Acta Neuropsychiatrica 1 Psychotherapy and Psychosomatics 1 Philosophical Psychology 1

Publication history

Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23 The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic reviewActa Neuropsychiatrica · 2026-06-09 Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26 Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyUnknown journal · 2026-05-07 SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH modelsJournal of Hepatology · 2026-04-30 Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-09 Psychedelics in NHS services: exploring a model for real-world implementation of psilocybinThe British Journal of Psychiatry · 2026-03-29 Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-03-17 Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative reviewBMJ Supportive & Palliative Care · 2026-02-17 Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-01-25 Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19 Persistent Altered States: Psychological Treatment of Psychedelic Adverse EffectsTidsskrift for Norsk psykologforening · 2025-11-30 Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.Unknown journal · 2025-10-30 Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24 Compassionate use of psilocybin for treatment-resistant depression in GermanyThe Lancet Psychiatry · 2025-09-22 N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiencesNeuropsychopharmacology · 2025-09-11 Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience QuestionnaireJournal of Psychiatric Research · 2025-05-25 FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-30 Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische AnwendungNervenheilkunde · 2025-04-30 The phenomenology of psilocybin: transformative insights for research and clinical practiceFrontiers in Psychology · 2025-04-24 Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysisProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-03-31 Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-01-31 Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytesDigestive and Liver Disease · 2025-01-31 Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paperEuropean Psychiatry · 2024-12-31 Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30)Journal of Psychedelic Studies · 2024-07-11 THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31 The influence of psilocybin on subconscious and conscious emotional learningiScience · 2024-05-18 Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13 Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-01-31 A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.Unknown journal · 2024-01-17 Synthesis and bioactivity of psilocybin analogues containing a stable carbon-phosphorus bondRSC Medicinal Chemistry · 2023-12-31 Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sampleFrontiers in Psychiatry · 2023-11-12 Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J miceNeuroscience Applied · 2022-12-31 Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.Nature Communications · 2022-10-02 Animal Behavior in Psychedelic Research.Unknown journal · 2022-09-30 Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.Network Neuroscience · 2022-09-30 Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience Applied · 2022-03-06 P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current statusEuropean Neuropsychopharmacology · 2021-11-30 Silencing indigenous pasts: critical Indigenous theory and the history of psychedelicsInternational Journal of Qualitative Studies in Education · 2021-06-20 Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.Proceedings of the National Academy of Sciences · 2021-03-31 Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in miceBehavioural Brain Research · 2020-12-27 Enzymatic Route toward 6-Methylated Baeocystin and PsilocybinChemBioChem · 2019-05-30 Psychedelic drugs in the treatment of anxiety, depression and addiction.Unknown journal · 2018-11-11 Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences · 2016-04-17 Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers.Unknown journal · 2014-08-09 Broadband cortical desynchronization underlies the human psychedelic state.Journal of Neuroscience · 2013-08-31 Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences · 2012-01-22

Author directory